Is Exicure Inc (XCUR) overvalued? · $13.7M cap
Exicure Inc (XCUR) is a biotechnology company listed on NASDAQ.
This page asks whether Exicure Inc (XCUR) looks expensive on cached numbers — not a short thesis.
Latest reported XCUR revenue for 2025-12-31 was $0. Net income was -$4.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. XCUR currently screens at market cap $13.7M.
XCUR currently screens at market cap $13.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next XCUR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the XCUR stock page for the full model, not this heading.
Not investment advice.